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Abstract
Background: Regulation of the mRNA life cycle is central to gene expression control and determination of cell fate.
miRNAs represent a critical mRNA regulatory mechanism, but despite decades of research, their mode of action is
still not fully understood.
Results: Here, we show that eIF4A2 is a major effector of the repressive miRNA pathway functioning via the Ccr4-
Not complex. We demonstrate that while DDX6 interacts with Ccr4-Not, its effects in the mechanism are not as
pronounced. Through its interaction with the Ccr4-Not complex, eIF4A2 represses mRNAs at translation initiation.
We show evidence that native eIF4A2 has similar RNA selectivity to chemically inhibited eIF4A1. eIF4A2 exerts its
repressive effect by binding purine-rich motifs which are enriched in the 5′UTR of target mRNAs directly upstream
of the AUG start codon.
Conclusions: Our data support a model whereby purine motifs towards the 3′ end of the 5′UTR are associated with
increased ribosome occupancy and possible uORF activation upon eIF4A2 binding.
Introduction
Two mRNA-binding complexes—eIF4F and Ccr4-Not—
play fundamental roles in directing the cytosolic fate of
mRNAs at the level of translation as well as mRNA
turnover. The eIF4F complex, consisting of the cap bind-
ing protein eIF4E, the regulatory scaffold protein eIF4G,
and the DEAD-box RNA helicase eIF4A, is recruited to
the 5′-cap structure of mRNAs and is required for trans-
lation [1]. eIF4A stimulates translation initiation and is
thought to be required for unwinding of secondary
structure in the 5′UTR to facilitate 40S ribosome scan-
ning [2–6] as well as allowing the loading of the mRNA
into the 43S pre-initiation complex (PIC) independently
of structure unwinding [7].
The miRNA repression apparatus orchestrates the de-
livery of the Ccr4-Not complex to target mRNAs, result-
ing in both translational repression and mRNA decay
[8–10]. Translational repression, which is the required
first step of miRNA-mediated silencing [11], can be in-
duced by the Ccr4-Not complex independently of its
deadenylation and degradation activities [12–15]. The
Ccr4-Not complex defines mRNA fate and sculpts the
translational landscape of the cell [16] well beyond
miRNA-mediated repression by binding to mRNAs via
its many partner RNA-binding proteins which recognize
a number of regulatory sequence motifs. At the core of
the Ccr4-Not complex lies the scaffold protein CNOT1,
which dictates the complex’s activity through its interac-
tions with other proteins, such as the deadenylases
CNOT7 and CNOT8—proteins required at the onset of
mRNA decay [16]. The central region of CNOT1 has
been shown to be sufficient for this repressive activity,
and structural work has revealed that this region of the
protein contains a MIF4G domain [17] similar to that
responsible for eIF4G’s interactions with eIF4A [18].
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This binding surface in CNOT1 has been shown to
interact with the DEAD-box protein DDX6 in the con-
text of miRNA-mediated repression [17]. DDX6 is a
well-established translational regulator and central com-
ponent of cytoplasmic mRNA degradation bodies (P
bodies) [19–21], but the mode of its recruitment to
mRNAs and mechanism of repression remain unknown.
The second DEAD-box protein implicated in miRNA-
mediated translational repression is eIF4A2. The two
cytoplasmic paralogs of eIF4A, eIF4A1 and eIF4A2, have
previously been reported to have redundant functions in
translation initiation through their interaction with
eIF4G as part of the eIF4F complex [22]. More recent
results suggest that they possess distinct activities [4],
and our previous work showed that unlike eIF4A1,
eIF4A2 is involved in miRNA-mediated repression and
associates with the Ccr4-Not complex component
CNOT7 [11, 23]. However, there have been reports con-
testing our findings regarding the activity of eIF4A2 in
miRNA-mediated repression [17, 24, 25]. Indeed, the na-
ture of the divergent functions of the eIF4A paralogs
and their respective roles in gene regulation are not yet
understood.
The molecular mechanism by which miRNAs inhibit
translation has been a matter of debate for many years.
Original observations showed that miRNAs influence
gene expression at a post-initiation stage of translation
[26] and were subsequently confirmed by other groups
[27–29]. Later, numerous studies showed that repression
was exerted at the initiation phase of protein synthesis
[30–33]. Investigations focusing on translation repres-
sion at initiation have highlighted the critical role of the
eIF4F complex in this process [11, 31, 34–36], a claim
that has nevertheless been contested [25]. The volume
of contradictory data attests to the fact that despite
much research, the precise mechanism of miRNA-
mediated translational repression remains unresolved.
The present study addresses the fundamental molecular
mechanisms of miRNA-mediated repression. We demon-
strate that eIF4A2 forms part of a large repressive complex
together with CNOT1. We show that eIF4A2 is predomin-
antly associated with mRNAs repressed at initiation in a
manner dependent on CNOT1. Interestingly, messages only
bound by DDX6 are not enriched for miRNA target families
nor are they repressed at initiation; however, mRNAs bound
by eIF4A2 are targeted by a distinct set of miRNA families
and are translationally upregulated following CNOT1
knockdown. In terms of RNA binding, eIF4A2 has high spe-
cificity for purine-rich RNA, similar to that of chemically
inhibited eIF4A1 [37]. We show repression via eIF4A2 is as-
sociated with the enrichment of purine-rich motifs towards
the end of the 5′UTR. We also show eIF4A2-bound mes-
sages have an increased prevalence of translation initiation
from upstream translation initiation sites.
Results
eIF4A2 forms an endogenous complex with CNOT1
eIF4A1 and eIF4A2 have been reported to have non-
redundant divergent roles in translation regulation [11,
38, 39], despite sharing 90% amino acid sequence iden-
tity (Additional file 1: Figure S1A) and original claims
that the two paralogs have identical activities [22]. To
gain a better understanding of the nature of the differ-
ences between the two proteins, we turned to previously
described dominant negative (D/N) mutations of
eIF4A1, which disrupt its RNA binding/unwinding cap-
acity but not its interaction with eIF4G [40], leading to
the formation of a functionally inactive eIF4F complex.
As eIF4A1 and eIF4A2 share sequence identity within
this motif (PTRELA, Additional file 1: Figure S1A), we
introduced these mutations into both proteins. Expres-
sion of D/N eIF4A1 resulted in inhibition of translation
of a luciferase reporter, but interestingly, expression of
mutant eIF4A2 did not (Additional file 1: Figure S1B).
This shows clearly that the two proteins have distinct
functions and suggests that eIF4A2 does not interact
strongly with eIF4G, as it would otherwise inhibit the
eIF4F complex and lead to translational repression.
Therefore, we examined the ability of both proteins to
interact with eIF4G. As reported previously [11], while
eIF4A1 could strongly interact with endogenous eIF4G,
eIF4A2 showed only a weak association (Additional file 1:
Figure S1C). This was not dependent on the cell line,
position of tag nor the type of tag present (Additional
file 1: Figure S1C) [11]. Previous reports had shown that
eIF4A2 is not able to rescue translation after eIF4A1 de-
pletion [38], and our observations confirm this. Of note,
we observed that unphysiologically high levels of eIF4A2
overexpression, as are often observed in transfection ex-
periments, can result in its association with eIF4G (Add-
itional file 1: Figure S1D). This suggests it is possible to
oversaturate the system, which might explain conflicting
results obtained by others [17, 25]. For this reason, we
attempted to perform as many experiments as possible
by investigating endogenous complexes.
We next sought to determine the amino acids within
eIF4A2 responsible for its altered association with
eIF4G. Despite the major sequence divergence between
eIF4A1 and eIF4A2 residing in the N-terminus (Add-
itional file 1: Figure S1A), the removal or exchange of
this region did not affect the association between eIF4A2
and eIF4G (Additional file 1: Figure S2A). Evolutionary
conservation of the amino acids in the N-terminus of
the two proteins is rather low; however, a number of
other sites which differ between eIF4A1 and eIF4A2
have been conserved following gene divergence (Add-
itional file 1: Figure S2B). Substituting amino acids at 7
specific sites (of a total of 41 non-identical amino acids
between the 2 proteins), dispersed along the N-terminal
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lobe of eIF4A2, into those present in eIF4A1 was suffi-
cient to restore binding to eIF4G (Fig. 1a, b). When the
eIF4A1 D/N mutations were added to this variant of
eIF4A2, it acquired the ability to repress translation in a
dominant negative manner (Fig. 1c). Superimposing
these amino acids on the previously solved eIF4A struc-
ture [42], we observe that they are all present on the sur-
face of the N-terminal lobe (Additional file 1: Figure
S2C), which raised the possibility that they create an
interaction site for another binding partner.
We had previously shown that eIF4A2 associates spe-
cifically with the deadenylase CNOT7, which is part of
the Ccr4-Not complex [11, 23]. To extend our know-
ledge of the differential binding partners of eIF4A1 and
eIF4A2, we conducted LC-MS/MS analysis of immuno-
precipitates of both endogenous proteins. These revealed
that eIF4A2 interacts with CNOT1, the central compo-
nent of the Ccr4-Not complex, as well as other compo-
nents of the Ccr4-Not complex, including CNOT7
(Fig. 1d). This strongly reinforces our previous observa-
tions that eIF4A2 associates with Ccr4-Not complex.
We confirmed these interactions and showed they were
RNA independent (Fig. 1e). Many of these have also
been validated in a separate study [23]. Several other
proteins identified as highly enriched in the MS/MS ana-
lysis in the eIF4A2 IPs are not only known to be part of
the mRNA turnover pathway, but are involved in
miRNA-mediated repression. For example, TRIM32 has
been shown to enhance the activity of miRNAs [43] and
associate with many protein components of the repres-
sion machinery, including DDX6, in mouse neural pro-
genitors [44]. Another of the interacting proteins,
CSNK1A1, was shown to regulate the efficiency of
miRNA-mediated repression through the phosphoryl-
ation of Ago2 [45]. Similarly, CLP1 acts as an activator
of miRNAs [46]. Finally, TNKS1BP1 (also known as
TAB182) has been previously identified as a component
of the Ccr4-Not complex [47]. Together, our findings
show that eIF4A2 interacts with a complex involved in
miRNA-mediated repression and the control of transla-
tion in general.
We further investigated this endogenous complex by
performing gel filtrations of cytoplasmic lysate from
HeLa cells, which revealed that both CNOT1 and
eIF4A2 are present within the same fractions (and
eIF4A1 levels are minimal in these fractions—see inputs
Fig. 1f and Additional file 1: Figure S3A) migrating at an
approximate molecular weight of 1.3MDa (Add-
itional file 1: Figure S3B). Reciprocal immunoprecipita-
tions of both eIF4A2 and CNOT1 from these fractions
show a strong RNA-independent interaction between
them (Fig. 1f). Other groups have been unable to show
an interaction between these two proteins [17, 24]. How-
ever, the critical difference is that the previous studies
used overexpression and partial fragments of CNOT1,
which may disturb either the complex formation or the
delicate stoichiometry between the regulatory proteins.
We, on the other hand, are investigating the endogenous
complexes using multiple different technical approaches,
and additional findings regarding these interactions have
been reported in a recent study [23]. An interaction be-
tween CNOT1 and DDX6 is not obviously apparent in
IPs from gel filtration fractions because of high back-
ground (Fig. 1f, right panel), but is readily detectable in
IPs from total lysate (Additional file 1: Figure S3C). This
could mean that DDX6- and eIF4A2-containing Ccr4-
Not complexes have different molecular weights result-
ing in differential migration through the gel filtration
columns. Together, these data show the existence of an
RNA-independent interaction of endogenous eIF4A2
with CNOT1.
eIF4A2-bound mRNAs are translationally repressed
Having obtained evidence of divergent activities and
binding partners of eIF4A1 and eIF4A2, we sought to
identify the mRNA interaction landscape of the two
eIF4A paralogs at physiological levels by performing en-
dogenous native RIP-Seq (Fig. 2a) [50]. While there was
a large overlap between bound mRNAs, our analysis
showed discrete groups of mRNAs were enriched in
binding to only one paralog (Fig. 2a) and we focused on
these in the first instance to identify distinctions be-
tween the roles of the two proteins. Specific enrichment
was confirmed by RT-qPCR in independent experiments
(Additional file 1: Figure S4A).
To gain a better understanding of how the eIF4As
affect translation, we conducted sucrose density gradi-
ents and performed RNA-Seq on the polysomal and sub-
polysomal fractions to distinguish mRNAs that are
highly associated with ribosomes from those that are
not. We then calculated the relative distribution of
mRNAs between the subpolysomal and polysomal frac-
tions. This method of analysis allowed us to differentiate
between mRNAs that are repressed at initiation of pro-
tein synthesis, which we expect to be more subpolyso-
mal, from mRNAs undergoing translation or repressed
at elongation, which would be expected to be more poly-
somal. We used this to evaluate the distribution of
mRNAs bound exclusively by each of the eIF4A para-
logs, as well as the group bound by both proteins, as
identified in the RIP-Seq. As expected for a protein in-
volved in translation initiation, eIF4A1-only associated
messages displayed a polysome distribution similar to
that of all mRNAs (Fig. 2b, Additional file 1: Figure
S4B). In contrast to this, eIF4A2-only bound mRNAs
displayed a markedly subpolysomal distribution, suggest-
ing attenuation of translation initiation. This strong as-
sociation with subpolysomes is particularly striking given
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the eIF4A2-bound mRNAs possess longer coding re-
gions (Additional file 1: Figure S4D), which one would
normally expect to be loaded with more ribosomes than
the average mRNA due to their length and as a result be
present in the higher polysomal fractions. This distribu-
tion is specific to the eIF4A2-bound mRNAs as a
group of length-matched mRNAs is not subpolysomal
(Additional file 1: Figure S4B, bottom panel). The large
group of mRNAs bound by both eIF4A1 and eIF4A2 is
also less associated with polysomes than the average
mRNA, but not as much as the eIF4A2-only group
(Fig. 2b).
To further investigate if the eIF4A2-bound mRNAs
are being repressed, we performed ribosome profiling to
obtain the precise distribution of the ribosomes along
the mRNA. Metagene analysis along the CDS supports
the polysome profiling data, showing eIF4A2-bound
mRNAs and those bound by both proteins to have re-
duced ribosome occupancy along the mRNA compared
to eIF4A1-bound mRNAs (Fig. 2c). These results could
be explained by either an initiation block or a higher
elongation speed, as has been suggested before [51, 52].
To differentiate between the two possibilities and test
the hypothesis that these mRNAs are repressed at initi-
ation, we turned to proteomic methodologies. Using
pulsed SILAC, we showed the polysome distribution of
the bound mRNAs is reflected in lower protein levels for
mRNAs exclusively bound by eIF4A2 and bound by
eIF4A1 and eIF4A2 compared to mRNAs not bound by
either of the paralogs (Fig. 2d, Additional file 1: Figure
S4C). The decreased protein levels for eIF4A2-bound
mRNAs are maintained when comparing to a group of
length-matched control mRNAs (Additional file 1: Fig-
ure S4C).
Since eIF4A2 has previously been implicated in
miRNA-mediated repression [11], and we observe that
eIF4A2-bound mRNAs are translationally repressed, we
examined the proportions of miRNA targets bound by
the protein. mRNAs bound by eIF4A2 or both eIF4A1
and eIF4A2 have a much higher proportion of miRNA
targets compared to mRNAs only bound by eIF4A1
(Fig. 2e). This supports the role of eIF4A2, but not
eIF4A1, in the miRNA pathway.
eIF4A2-bound mRNAs display increased ribosome
occupancy in the 5′UTR
In a ribosome profiling dataset, the majority of the
ribosome-protected fragments (RPFs) align to the CDS.
However, RPFs may be observed in the 5′UTR as a re-
sult of a block of translation initiation from the main
AUG and possible translation of upstream open reading
frames (uORFs) [25]. Analysis of our ribosome profiling
experiment revealed that eIF4A2-bound mRNAs are
enriched for RPF reads in the last 50 nt of their 5′UTR
compared to all mRNAs and eIF4A1-bound mRNAs
(Fig. 2f). Meanwhile, there is no difference in ribosome
occupancy in the first 50 nt of the 5′UTR. One of the
explanations for this observation could be the activation
of upstream open reading frames (uORFs) leading to re-
duced translation from the main AUG start codon of the
mRNAs.
Recently published global translation initiation sequen-
cing (GTI-seq) [49], also performed in HEK293 cells,
used lactimidomycin to obtain peaks of only initiating ri-
bosomes—this allows identification of active uORFs in
cells. We utilized these data to ask if the eIF4A2-bound
mRNAs have a tendency to possess active uORFs. Of the
detected mRNAs in the GTI-Seq dataset, a subset are
only translated from their annotated AUG start codon;
for some mRNAs, only the upstream translation initi-
ation site is active (referred to as uTIS); and for other
mRNAs, initiating ribosome peaks are found at both the
upstream and the annotated start sites. Interrogation of
the dataset revealed that there is a greater proportion of
eIF4A2-bound mRNAs with initiating ribosome peaks
only at the upstream and not at the annotated start site
compared to all other mRNAs (Fig. 2g). We also see in-
creased numbers of upstream initiation start sites in the
mRNAs bound by both eIF4A1 and eIF4A2, but no in-
creased ribosome density in the 5′UTR indicating that
these mRNAs may be subject to more complex interplay
between the two binding proteins. Looking in more
(See figure on previous page.)
Fig. 1 eIF4A2 is not a canonical component of eIF4F, but instead interacts with the Ccr4-Not complex. a Schematic of Flag-tagged proteins
expressed. b Immunoprecipitation of Flag-tagged proteins expressed in HEK293 cells transfected with the indicated constructs. IPs were
performed 48 h after transfection, and Western blots were probed with eIF4G antibody to show interaction. Western blot shows a representative
experiment of 5. c HEK293 cells were transfected with constructs depicted in a and a Renilla luciferase reporter plasmid. Cells were harvested
after 24 h, luciferase activity was measured and reporter mRNA was quantified by qPCR. Translational efficiency denotes luciferase activity over
RNA abundance, graph represents 3 independent experiments, and significance calculated from unnormalized data using Student’s t test, *p <
0.05, **p < 0.01. Western blot represents Flag-protein expression levels in one of the replicates . d LC-MS/MS analysis of endogenous eIF4A1 and
eIF4A2 IPs from HeLa cytoplasmic extract. Table shows quantitation of proteins using emPAI [41] specifically enriched in the eIF4A2 IP. Table
shows results from two experiments, one with two technical replicates. e Western blot confirmation of selected LC-MS/MS hits with and without
RNaseA digestion. IPs were performed for endogenous proteins. The pan-eIF4A antibody recognizes both eIF4A1 and eIF4A2. f. RNaseA-treated
IPs using indicated antibodies from gel filtration fractions of HeLa lysate enriched in CNOT1 and eIF4A2. The interaction between CNOT1 and
DDX6 is not as clear because of high background in the IgG IP (right panel). Asterisk denotes non-specific band from IgG
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detail at the upstream initiation, we observe no specific
trends for start site position (Additional file 1: Figure
S5A) or particular start codons driving this upstream
initiation in the eIF4A2-bound mRNAs compared to the
general features associated with uORFs (Additional file 1:
Figure S5 BC). To confirm the observations are due to
presence of uORFs and not an extension of the main
ORF, we looked at the frame of the uORF and observe
the majority of the uORFs are not in frame (Add-
itional file 1: Figure S5DE). This suggests eIF4A2 has a
role in reducing translation initiation at the main AUG
start codon at least partly on account of the presence of
active uORFs in the 5′UTRs of target mRNAs.
eIF4A2 binds mRNAs belonging to distinct functional
groups
Recent studies have highlighted the importance of eIF4A
activity in cancer [53–55], and while eIF4A1 expression
correlates with cell proliferation, that of eIF4A2 does not
[56]. GO term enrichment analysis revealed striking
functional differences between the mRNAs bound by the
two eIF4A paralogs (Additional file 1: Figure S6). eIF4A2
was associated with mRNAs encoding the miRNA bio-
genesis apparatus and proteins regulating neural tube
development as well as protein involved in negative
regulation of transcription—all predominantly nuclear
proteins. mRNAs bound by both proteins encode for
factors involved in signaling, cell cycle arrest, and trans-
lation. Interestingly, eIF4A1-bound mRNAs did not
show enrichment for a particular term in this analysis,
suggesting the protein is not selectively targeting specific
mRNAs.
eIF4A2 affinity and selectivity for purine-rich RNA is
comparable to that of inhibited eIF4A1
We next examined other sequence attributes of eIF4A-
bound mRNAs in detail. It had previously been reported
that the main function of eIF4A in translation initiation
was to unwind secondary structure in the 5′UTR and
several studies revealed the presence of specific GC-rich
sequence motifs in 5′UTRs of mRNAs regulated by
eIF4A1 [53–55]. Our experiments confirm that the
eIF4A1-bound mRNAs have higher 5′UTR GC content,
especially in the last 50 nt upstream of the AUG start
codon (Fig. 3a). To investigate whether the eIF4A2-
bound mRNAs bore any specific sequence motifs, we
conducted an unbiased motif search on the beginning
and end of both the 5′UTRs and coding sequences. This
showed eIF4A2-only bound messages have a specific en-
richment for purine-rich motifs in the last 50 nt of the
5′UTR and at the beginning of the coding region com-
pared to the eIF4A1-specific mRNAs (Fig. 3b). Interest-
ingly, it was previously reported that the inhibitor RocA
transforms eIF4A1 into a translational inhibitor that
clamps onto purine-rich motifs within 5′UTRs thus pre-
venting 40S scanning [37]. We confirmed that 5′UTRs
and coding sequences (CDS) of mRNAs bound only by
eIF4A2 are significantly enriched for purine-rich tetra-
mers that were identified as being the most commonly
bound by inhibited eIF4A1 in the RocA study (Fig. 3c),
especially directly upstream of the AUG start codon
(Fig. 3d). Taken together with the observation that
eIF4A2-bound messages have increased ribosome occu-
pancy in the 5′UTR compared to all mRNAs (Fig. 2f), as
was seen for 5′UTRs of mRNAs sensitive to inhibition
of eIF4A1 by RocA by Iwasaki et al. [37], this suggested
to us that uninhibited eIF4A2 might be displaying simi-
lar activity to RocA-inhibited eIF4A1. Under normal
conditions, eIF4A1 is not expected to act as a clamp and
thus should not have a binding preference for mRNAs
containing purine-rich motifs, and this is what we ob-
serve in the following set of experiments addressing both
RNA-binding specificity and selectivity.
To test the intrinsic capacity of these proteins for
RNA-binding, we performed in vitro assays with recom-
binant proteins. These showed that only eIF4A2 has
(See figure on previous page.)
Fig. 2 eIF4A2 represses translation at initiation. a Western blot demonstrates specificity of immunoprecipitation for each protein from a
representative experiment. Input represents 10% of lysate used in IP. Asterisk denotes non-specific signal from IgG. Venn diagram showing
numbers of mRNAs significantly (FDR < 0.05) enriched over input in the respective endogenous RIP-Seq (n = 3). b Differential association with
polysomes of mRNAs bound to one of the two proteins or both compared to all mRNAs identified in the RIP-Seq experiment. Relative
distribution of mRNAs on sucrose density gradients was calculated from RNA-Seq analysis of the subpolysomal and polysomal fractions in a
separate experiment (n = 4) by subtracting counts per million between the two fractions. Significance calculated using Dunn’s test with
Bonferroni’s correction. c Differential ribosome occupancy of eIF4A2- and eIF4A1-bound messages. Ribosome profiling was performed in HEK293
lysates (n = 3). Ribosome occupancy for each mRNA at each nt position is calculated as the number of ribosome footprints normalized to the
mRNA abundance (transcripts per million—TPM). Shown is the mean number of normalized ribosome footprints 75 codons downstream of the
AUG and upstream of the STOP codon. d iBAQ—intensity-based absolute quantification [48]—of protein abundance in control conditions in
pulsed SILAC for bound mRNAs. e Proportions of mRNAs bound by eIF4A1 and eIF4A2 predicted to be miRNA targets by the Targetscan
algorithm. f eIF4A2-bound mRNAs have increased ribosome occupancy in the last 50 nt, but not in the first 50 nt of the 5′UTR. The RPF coverage
was normalized for the abundance of the mRNAs (TPM). g Translation of the main AUG start codon is repressed by activation of uORFs in eIF4A2-
bound mRNAs. Global translation initiation sequencing (GTI-seq) data from Lee et al. [49], also conducted in HEK293 cells, was used to assess the
translation from uORFs in the groups of mRNAs bound by either eIF4A1, eIF4A2, or both. The stacked bars represent the proportions of the
groups of mRNAs with active translation from the annotated translation start site, upstream start sites, or both
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higher affinity and specificity for a single stranded un-
structured purine-rich RNA (ssRNA) composed of (AG)
repeats compared to a CA-only RNA, both with and
without the presence of the chemical inhibitor silvestrol
(Fig. 4a, b, Additional file 1: Figure S7AB), which acts in
the same manner as RocA [58]. Meanwhile, eIF4A1
binds both ssRNAs at a comparably high affinity. In con-
trast, both proteins show a tenfold weaker affinity to a
hairpin GCU-RNA (Fig. 4b). Addition of silvestrol in-
creases binding of both proteins to RNA, regardless of
sequence (Fig. 4a, b, Additional file 1: Figure S7A), as
has been reported for eIF4A1 previously [37]. Neither
protein showed any appreciable affinity for double-
stranded RNA (dsRNA) with or without silvestrol (Add-
itional file 1: Figure S7AB). Competition experiments,
where one ssRNA is pre-bound to the protein and the
competing purine-only RNA is added afterwards,
showed that both eIF4A paralogs have clamping proper-
ties on a purine-only (AG10) oligo, especially when com-
pared to eIF4H, a stimulator of eIF4A activity with
known low RNA-binding capacity [59] (Additional file 1:
Figure S7C). However, only eIF4A2 readily exchanged a
CA-only RNA for a purine-only RNA (Additional file 1:
Figure S7C), supporting the idea that the two paralogs
show differences in selectivity of RNA binding. Import-
antly, selectivity experiments both in the presence of
unhydrolysable AMPPNP (Fig. 4c) as well as ATP (Add-
itional file 1: Figure S7D), in which the proteins are pre-
sented two different RNAs at once, demonstrate a lack
of selectivity of eIF4A1 in RNA binding, while eIF4A2
displays a strong preference in binding a purine-only
RNA even under high molar excess of competitor RNA
(Fig. 4c). This observation is consistent with the differ-
ence in affinity and kinetic stability of eIF4A2 with the
CA-RNA (Fig. 4b and Additional file 1: Figure S7C).
Thus, uninhibited eIF4A2 shows selectivity for purine
sequences that is at similar levels to silvestrol-inhibited
eIF4A1 (Fig. 4c).
To confirm the in vitro results in the cellular context,
we conducted RNA-IPs for eIF4A1 and eIF4A2 with and
without RocA treatment (Additional file 1: Figure S8A)
followed by qPCR of the previously validated targets
(Additional file 1: Figure S4A). Following RocA treat-
ment, there is a strong increase in binding of eIF4A1 to
eIF4A2 targets (Additional file 1: Figure S8B), whereas
we see minimal impact on their binding to eIF4A2,
which is already bound to these mRNAs in control con-
ditions. This is what we would predict given previous
data for eIF4A1 acting as a translational repressor fol-
lowing RocA treatment [37].
Together, these data suggest that eIF4A2 has high af-
finity for and selective interaction with purine motifs
within mRNAs similar to that of inhibited eIF4A1, both
in vitro and in vivo. The enrichment of these motifs in
eIF4A2-bound mRNAs concurrently with an accumula-
tion of ribosome footprints in the 5′UTR is an indica-
tion that in this endogenous context, eIF4A2 shows
similarities to chemically inhibited eIF4A1 [37].
eIF4A2 represses translation of miRNA targets at initiation
via CNOT1
Since eIF4A2 had been previously implicated in miRNA-
mediated repression [11], it interacts with the Ccr4-Not
complex, and eIF4A2-regulated mRNAs were involved
in the miRNA pathway, we further investigated its role
in the miRNA silencing mechanism. We have shown
that eIF4A2 interacts with the Ccr4-Not complex, but
there is also ample evidence for DDX6 playing a role in
imposing miRNA-mediated repression via the Ccr4-Not
complex [4, 11, 17, 34, 35], which is the principal ef-
fector of translational repression and mRNA degradation
induced by miRNAs [60]. We therefore extended our
RIP-Seq study by performing DDX6 RNA-IPs to be able
to compare the mRNA-binding repertoires of the two
Ccr4-Not-interacting DEAD-box proteins (Fig. 5a, Add-
itional file 1: Figure S9A). This revealed a number of
mRNAs bound uniquely to eIF4A2 or DDX6, as well as
eIF4A1 (Fig. 5a, Additional file 1: Figure S9A).
Thus far, the data presented has suggested that
mRNAs bound by eIF4A2 are repressed at initiation,
possibly through the interaction with the Ccr4-Not com-
plex. To test this hypothesis, we performed RNA-Seq on
subpolysomal and polysomal fractions of sucrose density
gradients from cells with and without depletion of
(See figure on previous page.)
Fig. 3 eIF4A2 selectively binds to purine-rich motifs within 5′UTRs. All figures use the groups of mRNAs bound by either eIF4A1 or eIF4A2 as
depicted in the Venn diagram in Fig. 2a. a 6 nt rolling average GC content in the 5′UTR shows eIF4A1-bound mRNAs have increased GC content
at 3′ end of the 5′UTR. b Motif enrichment analysis of eIF4A2-bound mRNAs compared to eIF4A1-bound mRNAs as controls was carried out for
the first and last 50 nt of the 5′UTRs and coding sequences (CDS) using the MEME algorithm from the MEME Suite [57]. Shown are enriched
motifs with associated probabilities. c eIF4A2-bound mRNAs have a higher frequency of purine-rich motifs (AAGA, AGAA, GAAA, GAGA, AGAG,
GGAA, AAAA, GAAG) identified as targets of eIF4A clamping following chemical inhibition by RocA [37] in the 5′UTR and CDS. Cumulative
frequency plots depicting frequencies of purine-rich motifs in 5′UTRs, CDSes, and 3′UTRs, respectively, of bound mRNAs. Significance calculated
using Dunn’s test with Bonferroni’s correction. d eIF4A2-bound mRNAs have enrichment of purine-rich motifs directly upstream of the AUG start
codon. The first and last 50 nt of 5′UTRs of mRNAs bound by either eIF4A1 or eIF4A2 were used in analysis of enrichment over all mRNAs
identified in the RIP-Seq experiment. Significance calculated using Dunn’s test with Bonferroni’s correction
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CNOT1 (Fig. 5b, Additional file 1: Figure S9B). We then
compared the relative changes in polysome association
of mRNAs bound by the two Ccr4-Not partner pro-
teins—eIF4A2 and DDX6, and eIF4A1. Knockdown of
CNOT1 caused eIF4A2-only bound mRNAs to shift into
the polysomal fraction, as expected for mRNAs released
from repression at initiation (Fig. 5b). Unexpectedly
though, DDX6-only bound mRNAs shifted into the sub-
polysomal fraction (Fig. 5b). This is not what would have
been expected for a protein interacting with mRNAs
translationally repressed by the Ccr4-Not complex. We
confirmed these observations by RT-qPCR along every
fraction of the polysome gradient for representative
mRNAs that were also predicted miRNA targets
Fig. 4 a Equilibrium binding of eIF4A1 and eIF4A2 to RNA substrates. Direct fluorescence polarization measurement of 5′ FAM-RNA/eIF4A
association for wild-type eIF4A1 (gold) and eIF4A2 (red) in the absence (control) or presence (+ silvestrol) of 10 μM silvestrol. Representative plot
for 20 nt (AG)10 (solid lines), (CAA)6CA (dashed lines) oligo association. Raw data were converted to changes in anisotropy. Shown are the
mean ± SD of triplicates. b Dissociation constants (KD) of the binding of eIF4A1 and eIF4A2 to different FAM-labeled RNAs in the presence and
absence of silvestrol. c Schematic representation of the competition experiments with simultaneous incubation of multiple RNAs with eIF4A. The
binding of eIF4A1 and eIF4A2 with and without silvestrol to labeled (AG)10 in the presence of (CAA)6CA competitor ssRNA at increasing molar
excess was analyzed using EMSA. Dissociation constants have been derived from fitting the binding data. Data represents mean ± SD, n = 3
Wilczynska et al. Genome Biology          (2019) 20:262 Page 10 of 21
Fig. 5 Different miRNA families target mRNAs bound by eIF4A2 alone or eIF4A2 and DDX6. a Venn diagram showing numbers of mRNAs
enriched in RIP-Seq of eIF4A1, eIF4A2, and DDX6. b Depletion of CNOT1 shifts mRNAs bound by eIF4A2 into polysomes and mRNAs bound by
DDX6 alone out of polysomes, while eIF4A1-bound mRNAs do not show a consistent shift. RNA-Seq experiment n = 4. Significance was calculated
using the Dunn test with the Benjamini-Hochberg correction. Western blot shows a representative CNOT1 knockdown experiment confirming
efficient knockdown with vinculin as loading control. c Venn diagram shows numbers of mRNAs enriched in RIP-Seq when only considering
eIF4A2 and DDX6. mRNAs bound by eIF4A2, DDX6, or both (eIF4A2 + DDX6) as well as mRNAs upregulated following TNRC6A/B knockdown in
HEK293 cells (FDR < 0.05) were categorized according to target prediction for conserved miRNA families (Targetscan [61]). Enrichment of mRNAs
targeted by a particular miRNA family (for full list of families, see Additional file 2: Table S1) in each group was assessed using Fisher’s exact test.
Heatmap presents enrichment below an adjusted p value (FDR) of 0.05, as well as between 0.05 and 0.1 and between 0.1 and 0.2, to show
consistency even with lower stringency cutoffs. d Pulsed SILAC labeling for 14 h was performed following 34 h of CNOT1 or control knockdown.
Violin plot shows ratios of labeled proteins for proteins encoded by mRNAs bound by indicated proteins. Each group was divided into miRNA
“target” and “non-target” as assessed by up- or downregulation following TNRC6A/B knockdown
Wilczynska et al. Genome Biology          (2019) 20:262 Page 11 of 21
(Additional file 1: Figure S10). Meanwhile, the eIF4A1-
only bound mRNAs did not show a trend in shifting to
either the sub- or the polysomal fractions (Fig. 5b). We
examined the mRNAs that shifted in polysome distribu-
tion following CNOT1 depletion for conserved miRNAs
targets and subdivided these based on association with
eIF4A1, eIF4A2, and DDX6. This analysis revealed that
predicted miRNA targets are more associated with
eIF4A2 than either eIF4A1 or DDX6 (Additional file 1:
Figure S11C).
To further investigate this, we focused on DDX6 and
eIF4A2 on account of their described role in both the Ccr4-
Not complex and miRNA-mediated regulation [11, 17, 23,
42], as opposed to eIF4A1 which is associated with the eIF4F
initiation complex [18, 53, 55] (Fig. 1, Additional file 1: Fig-
ure S1). We subdivided our RIP-Seq results between eIF4A2
and DDX6 and examined the mRNAs bound specifically to
only one or bound by both proteins for miRNA target sites
in their 3′UTRs. To create a reference dataset, we con-
ducted RNA-Seq following knockdown of TNRC6A/B, the
two highly expressed members of the TNRC6 family of pro-
teins which are the key effectors of the miRNA pathway
[62] (Additional file 1: Figure S9C). miRNA targets are spe-
cifically upregulated following TNRC6 depletion [8], and
thus, this dataset can be considered to be a faithful represen-
tation of miRNA targets in our cell line. Enrichment analysis
for miRNA targets among mRNAs bound by eIF4A2 and
DDX6 was compared to mRNAs upregulated following
TNRC6A/B depletion. This revealed, as expected, that tar-
gets of many conserved miRNA families were increased after
TNRC6A/B knockdown (Fig. 5c). Strikingly, different sets of
miRNA families were enriched among mRNAs only bound
by eIF4A2 and those bound by both eIF4A2 and DDX6
(Fig. 5c, Additional file 2: Table S1). mRNAs bound only by
DDX6 did not display significant enrichment for any con-
served miRNA families (though this of course does not
mean there are not many miRNA targets in this group, only
that the mRNAs are not enriched for conserved miRNA
family targets). Interestingly, from our RIP-Seq, we observed
that DDX6 associated strongly with mRNAs encoding P-
body components, RNA processing machinery, and proteins
involved in mitochondrial function, most of which are cyto-
solic in nature (Additional file 1: Figure S9E). It is remark-
able that the repertoire of mRNAs bound by DDX6
comprises so many mRNAs encoding proteins involved in
the very pathways DDX6 has been shown to be active in,
suggesting that DDX6 may form an RNA regulon [63].
As DDX6 has been implicated in translational repres-
sion, we asked whether we observe evidence of reduced
ribosome occupancy for mRNAs bound by the protein.
When comparing mRNAs bound specifically by either
eIF4A2 or DDX6 (see Venn diagram Fig. 5c), our ribo-
some profiling data showed that eIF4A2-bound mRNAs
had much lower ribosome occupancy than mRNAs
specifically depleted in the eIF4A2 IPs (Additional file 1:
Figure S11A). In contrast, DDX6-bound mRNAs showed
minimal differences in ribosome occupancy compared to
mRNAs depleted in the DDX6 IPs and we were able to
confirm that the polysome association of these mRNAs is
puromycin sensitive (Additional file 1: Figure S11B).
DDX6 is reported to stimulate decapping, which is pre-
ceded by deadenylation of the mRNA, so we further
looked at the poly(A) tail length of DDX6-bound mRNAs
using data from Subtelny et al. [64] This shows DDX6-
bound mRNAs have shorter poly(A) tails compared to
mRNAs not enriched for binding either eIF4A2 or
DDX6 and eIF4A2 (Additional file 1: Figure S11D). Divid-
ing the bound mRNAs by whether or not they are targeted
by miRNAs then highlighting only the predicted miRNA
target mRNAs shows the same polysome shifts following
CNOT1 depletion for eIF4A2-bound and DDX6-bound
mRNAs shown in Fig. 5b (Additional file 1: Figure S11E).
This led us to ask what the effects of CNOT1 depletion
were on protein output from these mRNAs. For this, we
performed pulsed SILAC experiments with or without
knockdown of CNOT1. eIF4A2-bound mRNAs showed
increased levels of proteins following CNOT1 depletion,
as opposed to those bound by DDX6 (Fig. 5d). We subdi-
vided these groups, designating those upregulated in the
TNRC6A/B knockdown RNA-Seq as genuine targets of
miRNAs in our cells. As expected for a protein involved in
this pathway, eIF4A2-bound miRNA targets were
expressed at levels over and above non-target eIF4A2-
bound mRNAs upon CNOT1 depletion (Fig. 5d). In fact,
when we consider all mRNAs immunoprecipitated with
respect to whether they are enriched either in the eIF4A2
IP versus the DDX6 IP, we see a robust increase in protein
expression of miRNA targets following CNOT1 depletion
in those preferentially bound by eIF4A2 (Additional file 1:
Figure S9F). Meanwhile, no such effects were observed for
the DDX6-bound mRNAs. This further supports the role
of eIF4A2 in miRNA-mediated repression through its
interaction with the Ccr4-Not complex.
Discussion
The two closely related paralogs of eIF4A, eIF4A1 and
eIF4A2, have been previously shown to have similar activity
in in vitro assays [22]. However, recent studies examining
their function in cellular systems have found their actives
differ and that they are in fact not functionally redundant
[11, 23, 38, 65, 66]. Unlike eIF4A1 which is part of the
eIF4F complex, a number of reports have indicated that
eIF4A2 interacts with components of the Ccr4-Not com-
plex and is involved in miRNA-mediated repression [11,
23, 65, 67], although this has also been contested [17, 25,
68]. The details of how these two closely related proteins
differ were unknown. Here, we show that the two paralogs
of eIF4A differ in their abilities to interact with eIF4G and
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determine the amino acids that distinguish these character-
istics (Fig. 1a–c, Additional file 1: Figure S1 and S2). We
further validate the interaction of endogenous eIF4A2 with
components of the Ccr4-Not complex (Fig. 1d–f, Add-
itional file 1: Figure S3). Previous reports had identified en-
dogenous eIF4A2 interacting with the Ccr4-Not complex
[11, 23, 65, 67], while others using overexpression ap-
proaches with either full-length or truncated versions of
these proteins have refuted these observations [17, 25].
These discrepancies are most likely due to different tech-
nical approaches, and importantly, our work has focused
on characterizing endogenous complexes.
eIF4A, the archetypal DEAD-box protein, has long
been thought to act primarily as a helicase which un-
winds secondary structure in the 5′UTRs. DEAD-box
proteins are known to also possess strand annealing and
clamping capacity [4, 6, 69]. The third paralog of eIF4A,
eIF4A3, functions as a molecular clamp as part of the
exon junction complex [70] and preferentially binds to a
purine-rich sequence motif [71]. In addition, eIF4A1 has
been shown to become a clamp upon chemical inhib-
ition with a silvestrol derivative, binding to purine-rich
motifs and preventing ribosome progression along the
mRNA [37]. We have provided evidence that eIF4A2-
bound mRNAs are repressed at translation initiation,
and we find that these mRNAs are enriched in their 5′
UTR for purine motifs, ribosome occupancy, and uORFs
(Figs. 2 and 3, Additional file 1: Figure S5), similar to
eIF4A1 inhibited with RocA on purine-rich motifs near
the start codon [37]. This repression at initiation results
in these mRNAs producing less protein (Fig. 2d). Inter-
estingly, purine motifs downstream of the uTIS have
been shown to be sufficient to increase translation from
the uTIS [25]. Our data is in line with this, and we see
examples of purine motifs both within and outside of
the uORF. However, we lack sufficient resolution to
make a definitive conclusion about the precise location
of these motifs and uTIS utilization.
Strikingly, in vitro experiments using purified proteins
show that eIF4A2 binds purine-rich oligos with high se-
lectively and affinity (Fig. 4, Additional file 1: Figure S7).
We observe that the selectivity of eIF4A2 for AG-RNA
is similar to that of silvestrol-inhibited eIF4A1 in the
presence of either AMPPNP or ATP (Fig. 4c, Additional
file 1: Figure S7D). While this similarity is striking, the
underlying molecular mechanism may be different; in
fact, our data show that the off-rate for AG-RNA is dif-
ferent between eIF4A2 and silvestrol-inhibited eIF4A1
(Additional file 1: Figure S7C).
From our RIP-seq data, we see that mRNAs associated
with eIF4A2 are enriched for purine sequence motifs
(Fig. 3b–d). In cells, we used RIP-qPCR to further dem-
onstrate that RocA enables eIF4A1 to recover these
eIF4A2 purine-rich targets (Additional file 1: Figure S8).
Common sequence motifs can provide a mechanism for
co-regulation, sorting, and subcellular co-localization of
RNA regulons [63]. mRNAs that were enriched in the
eIF4A2 IPs are also highly enriched for mRNAs stored
in P bodies [72] (Additional file 1: Figure S9D), suggest-
ing that mRNAs interacting with eIF4A2 are targeted to
sites of mRNA storage. Meanwhile, DDX6-bound
mRNAs are enriched for mRNAs encoding component
proteins of P bodies and RNA turnover machinery
(Additional file 1: Figure S9E) and thus may be involved
in regulating their expression—a possibility that requires
further investigation.
The Ccr4-Not complex has been shown to have multiple
roles in the regulation of gene expression [16] and is re-
cruited to mRNAs targeted by miRNAs where it is believed
to act to deadenylate and translationally repress miRNA-
targeted mRNAs [8–15]. Repression imposed by miRNAs
and the Ccr4-Not complex has been shown by many
groups to operate at the level of translation [30–33]. Here,
we show that the mRNAs that interact specifically with
eIF4A2 are enriched for predicted miRNA target sites
(Figs. 2e and 5c, Additional file 1: Figure S11C) and that de-
pletion of the Ccr4-Not complex component CNOT1 leads
to their redistribution onto polysomes (Fig. 5b, c, d, Add-
itional file 1: Figure S11E), consistent with translation re-
pression at initiation. eIF4A2-associated mRNAs also show
increased protein production by pulsed SILAC (Fig. 5d), to-
gether suggesting the Ccr4-Not complex is required for re-
pression of these mRNAs. There are of course many
mRNAs that our RIP-Seq showed as binding to both
eIF4A1 and eIF4A2, and these mRNAs may be regulated
by multiple mechanisms and the two proteins may act in
tandem. Interestingly, a recent publication showed that
eIF4A2 and CNOT1 cooperate in the unusual mechanism
through which the HCV virus utilizes host miR-122 mole-
cules for activation [65].
We have characterized the endogenous complex in
which eIF4A2 associates with the Ccr4-Not complex and
find it to contain multiple components of translation re-
pression machinery (Fig. 1d–f, Additional file 1: Figure
S3). Previous studies had not investigated purely en-
dogenous complexes [17, 24], and this has likely been
the reason for conflicting results. The use of RIP-seq to
obtain eIF4A2 and DDX6 mRNA targets has provided a
transcriptome-wide view of their roles in translational
regulation and allowed us to examine mRNAs predicted
to be regulated by miRNAs (Fig. 5c, d, Additional file 1:
Figure S11C).
Despite there being ample evidence for the interaction
of DDX6 with the Ccr4-Not complex, our data does not
suggest that DDX6 is specifically associated with pre-
dicted miRNAs’ target mRNAs (Fig. 5c, Additional file 1:
Figure S11C). This is perhaps explained by DDX6 having
a broader role in mRNA regulation, as has been
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suggested previously [21]. It cannot be excluded that
DDX6 exerts post-initiation repression on bound
mRNAs, as has been suggested for the yeast homolog
Dhh1 [73], but our proteomic studies were unable to
show an upregulation of DDX6-associated mRNAs fol-
lowing CNOT1 depletion (Fig. 5d, Additional file 1: Fig-
ure S9F) which may demonstrate that its role within the
Ccr4-Not complex is more complicated than previously
suggested. What we do observe instead is DDX6-bound
mRNAs showing a slight shift out of polysomes follow-
ing CNOT1 knockdown (Fig. 5b), which might mean
these mRNAs are subject to compensatory translational
“buffering” [74].
Conclusions
We have demonstrated that eIF4A2 has distinct activity
from eIF4A1 and that it acts to repress initiation of
translation of bound mRNAs. Our data implies that this
occurs though binding of purine-rich motifs. Moreover,
we show that eIF4A2 is in complex with CNOT1 and is
involved in miRNA-mediated repression in conjunction
with the Ccr4-Not complex.
Materials and methods
Cell culture
All cell lines are maintained in Dulbecco’s modified Ea-
gle’s medium (DMEM, GibCo) fortified with 10% fetal
bovine serum and 2mM L-glutamine. Cells were myco-
plasma tested.
Plasmid constructs and mutagenesis
Flag-eIF4A1 and Flag-eIF4A2 constructs were as previ-
ously described [11]. The 4A2N-4A1C and 4A1N-4A2C
mutants were made by introducing BamHI sites as silent
mutations into eIF4A1 and eIF4A2 coding sequence using
mutagenesis primers 4A1 E18 BamHI mutF, 4A1 E18
BamHI mutR, 4A2 D18 BamHI mutF, and 4A2 D18
BamHI mutR (see Additional file 2: Table S2). These con-
structs were then digested with BamHI, and the inserts
were cloned into a similarly digested reciprocal Flag con-
struct. The 4A1Δ1-16 and 4A2Δ1-13 constructs were cre-
ated by introducing SalI and BamHI (Additional file 2:
Table S2), respectively, into the coding sequences and
digesting out the intervening insert. Point mutations were
introduced by site-directed mutagenesis (SDM) using na-
tive PfuUltra (Agilent). Mutations introduced into eIF4A2
sequence: Flag-eIF4A2 5xM: N34S, K41S, E101A, N143A,
A150M; Flag-eIF4A2 7xM: N34S, K41S, E101A, N143A,
A150M, S207N, I208T, and dominant negative mutations
were introduced by SDM using primers listed in
Additional file 2: Table S2. pRL-SV40 plasmid used in lu-
ciferase assay experiments was described previously [11].
N-terminal His-HA-tagged eIF4A1 and eIF4A2 were gen-
erated by excising either C-terminal flag-myc tagged
eIF4A1 (Origene Inc.) or untagged eIF4A2 described pre-
viously [11] with AsiSI and NotI (NEB) restriction
enzymes. The excised product was then gel purified and
re-ligated into the N-terminal His-HA tagged pCMV6
backbone (Origene Inc., ps10017). A stop codon was
inserted after the eIF4A1 ORF to remove extra linker resi-
dues. The Flag-eIF4G plasmid was a kind gift from Mark
Coldwell. Primers used are listed in Additional file 2:
Table S2.
Tagged protein immunoprecipitations
Immunoprecipitation of Flag-tagged proteins was per-
formed as described previously [11], with the exception
that proteins were eluted from beads after washing using
200 ng/μl 3×Flag peptide (Sigma). Immunoprecipitation
of HA-tagged proteins was performed using the same
conditions, except that anti-HA agarose beads (Sigma
A2095) were used and elution was performed with the
HA peptide (Sigma I2149).
Immunoprecipitations for mass spectrometry and gel
filtration fractions
Cytoplasmic HeLa lysate (Ipracell) was diluted in buf-
fer (20 mMTris-HCl pH 7.5, 200 mM NaCl, 2.5 mM
MgCl2, 0.5% Triton X-100) and precleared by incuba-
tion at 4C for 1 h with rotation in the presence of
Dynabeads ProteinG (Invitrogen). The precleared ly-
sates were incubated with antibody (eIF4A1—abcam
ab31217; eIF4A2—abcam 31218; rabbit IgG—Santa
Cruz sc-2027). After an hour, protein G Dynabeads
preblocked with BSA and tRNA were added and the
mixture incubated for another 2 h. Beads were washed
three times for 10 min and then resuspended in SDS-
PAGE loading buffer and analyzed by mass spectrom-
etry. Immunoprecipitation following gel filtration was
performed as above with the following modifications:
The buffer used was 5% (w/v) sucrose, 0.1% (w/v)
CHAPS, 20 mM HEPES/NaOH, 5 mM DTT, and 50
mM NaCl, pH 7.0. Antibodies as stated above with
the addition of DDX6 (abcam ab70955) and CNOT1
(Protein Technologies 14276-1-AP). Where indicated,
RNaseA was added to the IP buffer at a concentration
of 5 μg/ml and SuperaseIn at 10 U/ml.
Luciferase assays
For dominant negative experiments, 6 × 104 HEK cells
were plated per well in a 24-well plate. Cells were trans-
fected using GeneJammer and 150 ng protein-encoding
plasmid, 10 ng pRL-SV40, and 40 ng pGL3. Cells were
harvested after 48 h, and luciferase assays were per-
formed as described previously [11].
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Mass spectrometry
Protein samples were separated on SDS-PAGE gels,
Coomassie stained, serially sectioned, and digested with
trypsin overnight, and peptides extracted and dried be-
fore analysis on a Synapt G2S mass spectrometer as de-
scribed previously [75–77]. HDMSe data were processed
and searched using Proteinlynx Global Server (Waters,
Manchester, UK) against a reversed human Swissprot
database. The results were visualized using Scaffold
(Proteome Software, OR, USA), the filters were set at
high stringency to give a protein FDR of 0.0%, and the
emPAI results were generated using quantitative analysis
in Scaffold. PLGS data files were then loaded in into
Scaffold (Proteome Software. Portland, OR, USA), and
peptide counts (SAF, spectral abundance factor) calcu-
lated as previously described [75].
SILAC
SILAC-labeled HEK293 cells were obtained by culturing
in SILAC-DMEM lacking arginine and lysine (Life Tech-
nologies) supplemented with [13C6] L-arginine and
[13C6] [15 N2] L-lysine(SILAC medium—M) (Sigma-Al-
drich) or [13C6][15 N4] L-arginine and [2H4] L-lysine
(SILAC heavy—H; Cambridge Isotope Laboratories,
Tewksbury, MA) for 14 h. Each comparison was done in
the forward (H/M) and reverse (M/H) directions. After
this, cells were harvested into SDS-free RIPA buffer. One
hundred fifty micrograms of each quantified SILAC-
labeled lysates was mixed in a 1:1 ratio, total protein
amount of 300 μg. Samples were then reduced with DTT,
to a final concentration of 5mM, and alkylated with IAA,
final concentration of 50mM. Samples were then subject
to a two-step digestion, firstly with Endoproteinase Lys-C
(ratio 1:33 enzyme:lysate) for 1 h at room temperature
then with trypsin (ratio 1:33 enzyme:lysate) overnight at
37 °C. The digested SILAC samples were fractionated
using reverse phase chromatography at pH 10. Solvents A
(98% water, 2% ACN) and B (90% ACN, 10% water) were
adjusted to pH 10 using ammonium hydroxide. Three
hundred micrograms of digested peptides were loaded
onto a Kinetex C18 column (150 × 2.1mm) coupled with
a Dionex Ultimate 3000 HPLC system, software version
6.7 (Chromeleon). Injected peptides were subject to a
two-step gradient, 4–27% solvent B in 36mins then 27–
48% solvent B in 8min. The flow rate was set to 200 μl/
min. The samples were collected into 21 fractions. Peptide
samples were run on the Q-Exactive HF mass spectrom-
eter coupled to an EASY-nLC II 1200 chromatography
system (Thermo Scientific). Samples were loaded into a
20-cm fused silica emitter, packed in-house with
ReproSIL-Pur C18-AQ, 1.9 μm resin, which was heated to
35 °C using a column oven (Sonation). Peptides were
eluted at a flow rate of 300 nl/min over three optimized
two-step gradient methods for fractions 1–7, 8–15, and
16–21. Step 1 was commenced for 20min, and step 2 for
7 mins. For fractions 1–7, the percentage of solvent B was
2–20% at step 1 and 39% at step 2; for fractions 8–15, 4–
23% at step 1 and 43% at step 2; and for fractions 16–21,
6–28% at step 1 and 48% at step 2. Peptides were electro-
sprayed into the mass spectrometer using a nanoelec-
tropsray ion source (Thermo Scientific). An Active
Background Ion Reduction Device (ABIRD, ESI Source
Solutions) was used to decrease air contaminants. Data
was acquired with the Xcalibur software (Thermo Scien-
tific) in positive mode utilizing data-dependent acquisi-
tion. The full scan mass range was set to 375–1400m/z at
60,000 resolution. Injection time was set to 20ms with a
target value of 3E6 ions. HCD fragmentation was triggered
on the 15 most intense ions for MS/MS analysis. MS/MS
injection time was set to 50ms with a target of 5E2 ions.
Ions that have already been selected for MS/MS were dy-
namically excluded for 25 s. MS raw data was processed
using MaxQuant software [78] version 1.6.3.3 and
searched with the Andromeda search engine [79] against
the Uniprot Homo sapiens database (95,146 entries). First
and main searches were done with a precursor mass toler-
ance of 20 ppm and 4.5 ppm, respectively. MS/MS mass
tolerance was set to 20 ppm. Minimum peptide length
was set to 6 amino acids, and trypsin cleavage was selected
allowing up to 2 missed cleavages. Methionine oxidation
and N-terminal acetylation were selected as variable modi-
fications and carbamidomethylation as fixed modification.
False discovery rate for peptide and protein identification
was set to 1%. SILAC multiplicity was set to 3, and the
medium (Arginine 6 and Lysine 4) and heavy (Arginine 10
and Lysine 8) labels were selected. MaxQuant output was
processed using Perseus software [80] version 1.6.2.3. Re-
verse and potential contaminant proteins were removed
as well as proteins identified only by site and those that
did not have at least one uniquely assigned peptide. For
protein amounts in control conditions, iBAQ values were
calculated using MaxQuant. For relative protein amounts,
H/M and M/H ratios from MaxQuant were used. Two
replicates—forward and reverse labeled—were analyzed.
Gel filtration chromatography
Protein complexes in cytoplasmic HeLa lysate (Ipracell)
were separated by size-exclusion chromatography using
a HiPrep 16/60 Sephacryl S-500 HR column connected
to an AKTApurifier protein purification system (GE
Healthcare Life Sciences, Buckinghamshire, UK), essen-
tially as described previously [81–83]. The column was
eluted at 4 °C with 5% (w/v) sucrose, 0.1% (w/v) CHAPS,
20 mM HEPES NaOH, 5mM DTT, and 150 mM NaCl,
pH 7.0, at 0.15 ml/min and 2ml fractions collected. The
column was calibrated with protein standards (GE
Healthcare Life Sciences) as shown in Additional file 1:
Figure S3B.
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RIP-Seq
Immunoprecipitation was performed using a modified
version of the method described previously [50]. This
methodology involves a very short, 20-min immunopre-
cipitation to limit non-specific binding of mRNA to
beads. This allowed us to isolate endogenous mRNA-
protein complexes. HEK293 cells were harvested and
lysed in lysis buffer (20 mM Tris pH 7.5, 200 mM NaCl,
5 mM MgCl2, 0.5% Triton-X100, 1× protease inhibitors
(Roche), 1% BSA, 0.5 mM DTT, 5 mM NaF, 40 U/ml
RiboLock (Thermo)). Lysates were spun down at 5000
rpm for 10min, and supernatants used in subsequent
steps. Aliquots were retained for total mRNA prepar-
ation. Protein G Dynabeads (Invitrogen) were pre-
incubated with antibodies at a ratio of 1 μg antibody to
4.5 μl Dynabeads with rotation for 2.5 h in lysis buffer at
4C. For each 2 × 106 cells, 8 μg of eIF4A1 antibody
(ab31217), 4 μg of eIF4A2 antibody (ab31218), 4 μg of
DDX6 antibody (ab70455), and 8 μg of rabbit IgG were
used. Pre-incubated beads were washed 3 times with
lysis buffer. Lysate was added to the washed beads and
incubated at 4C with rotation for 20 min to minimize
background. Beads were washed 3 times with lysis buf-
fer. RNA from beads and total fractions was extracted
using Trireagent (Invitrogen) followed by an additional
acid phenol (Ambion) extraction. One microgram of
RNA was subjected to library preparation using the Tru-
Seq Stranded mRNA library preparation kit followed by
NextSeq500 High Output 75 cycle sequencing. The RIP-
Seq was performed in triplicate.
Ribosome profiling sample and library preparation
The ribosome profiling methodology was adapted from
the protocol from Ingolia 2012. 3 × 10 cm plates of
HEK293 cells were used per condition. Medium was
changed 1.5 h prior to treatment with cycloheximide
(CHX) at 100 μg/ml at 37 °C for 3 min. Cells were then
washed with PBS-CHX (100 μg/ml) and lysed in 400 μl
lysis buffer (20 mM Tris-Cl pH 7.4, 150 mM NaCl, 5 mM
MgCl2, 1 mM DTT and 100 μg/ml CHX, 25 U/ml Turbo
DNase, 1% Triton X100). Prior to digestion, 50 μl lysate
was retained for total RNA samples and extracted with
Trizol. Four hundred sixty microliters of lysate was
digested with 11.6 μl RNase I (Ambion) for 40 min at
22 °C 650 rpm. The digestions were stopped with 14.8 μl
Superase.In (Invitrogen). Three hundred microliters of
the digestion was used for sucrose cushions (900 μl 1M
sucrose in polysome buffer), spun for 4 h at 70,000 rpm
4 °C. Pellets were then resuspended in 700 μl Qiazol and
extracted using the miRNeasy kit (Qiagen) following the
manufacturer’s instructions and eluted in 2× 40 μl
RNase-free water. Three hundred twenty microliters of
TE buffer was added to each sample before loading on
100 k columns (Amicon), which were spun at 12,000
rpm for 12 min at 20 °C. The filtrate was retained and
ethanol precipitated overnight at − 20 °C. This was re-
peated in triplicate followed by library preparation.
The RPF samples and markers at 500 nM (28 nt AGC-
GUGUACUCCGAAGAGGAUCCAACGU[phos], 34 nt
AUGUACACGGAGUCGACCCAACGCGA[phos]) were
run on a 15% TBE-Urea gel, stained with Sybr Gold (1
in 10,000), and imaged on a Typhoon Phospho Imager.
The RPF sample region was extracted from the gel using
the 28 nt and 34 nt oligos as markers (inclusive of 28 nt
and exclusive of 34 nt). The gel piece was broken up,
and the RPFs extracted in 400 μl RNA extraction buffer
(300 mM NaOAc pH 5.5, 1 mM EDTA, 0.25% SDS)
shaking overnight at 16 °C 550 rpm. The gel pieces were
removed using Spin-X columns, and the RNA was iso-
propanol precipitated on dry ice. T4 PNK (NEB,
M0201S) was used for 5′ phosphorylation and 3′ de-
phosphorylation at 37 °C for 1 h. Five microliters of 10
mM dATP was added, and the samples incubated at
37 °C for a further 30 min followed by 65 °C for 20 min.
The sample was then precipitated with isopropanol on
dry ice. For rRNA depletion, the RiboZero gold kit was
used according to the manufacturer’s protocol with 10 μl
rRNA depletion solution and ethanol precipitated at −
20 °C overnight. Ribosome-protected fragment libraries
were prepared using Biooscientific Nextflex small RNA
kit using 100 ng as input, 10 PCR cycles and with the gel
extraction option. Total RNA libraries were prepared
using the Biooscientific NEXTflex directional qRNA-Seq
kits with 10 PCR cycles. The libraries were sequenced
on NextSeq 75-cycle high output.
RT-qPCR
For IP validations (Additional file 1: Figure S4A, S9A),
RT-PCR was conducted on 50 ng of the RNA extracted
from the IPs and the 10% input RNA using SuperScript
III (Invitrogen). Primers were designed for RNAs found
to be enriched in each of the IPs as well as RNAs
enriched/depleted in all IPs (Additional file 2: Table S2).
qPCR was conducted using Fast SYBR Green PCR Mas-
ter Mix on a 7500 Fast Real Time PCR System (Applied
Biosystems) with three technical replicates for two bio-
logical replicates. ΔCT of IP to input was used for rela-
tive quantification.
RT-qPCR for samples treated with 0.3 μM DMSO or
0.3 μM RocA (Additional file 1: Figure S8B) for 30 min
prior to harvesting were conducted as described above.
ΔCT of IP to input per condition and ΔΔCT RocA to
DMSO were used for relative quantification of the
change in enrichment in IP binding following RocA
treatment.
For qPCR of gradient fractions (Additional file 1: Figure
S10), RT-PCR was conducted on equal volumes of RNA
from each gradient fraction with three technical replicates
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for two biological replicates. The proportion of the mRNA
present in each fraction is plotted. Primers used are listed
in Additional file 2: Table S2.
siRNA knockdowns and RNA-Seq of total mRNA
HEK293 cells were plated at 106 per 10 cm plate 24 h before
transfection with 30 nM siRNA (control siRNA #3 from
Dharmacon; specific siRNA from Ambion: CNOT1—ID no.
S22844, TNRC6A—ID no. S26154, TNRC6B—ID no.
S23060) and Dharmafect 1. Forty-eight hours after transfec-
tion, cells were harvested by scraping into ice cold PBS, spun
down, and directly extracted in Trireagent (Invitrogen)
followed by acid phenol (Ambion) extraction. Four
micrograms of RNA was subjected to library preparation
using the TruSeq Stranded mRNA library preparation kit
followed by NextSeq500 High Output 75 cycle sequencing.
The TNRC6A knockdowns were sequenced in duplicate,
and CNOT1 knockdown sequencing performed in
quadruplicate.
Sucrose density gradient RNA-Seq and RT-qPCR
Cells were transfected as above. Forty-eight hours after
transfection, cells were harvested by scraping into ice
cold PBS and lysed in lysis buffer (15 mM TrisHCl (pH
7.4), 15 mM MgCl2, 0.15M NaCl, 1% Triton X-100, 0.1
mg/ml cycloheximide, and 1mg/ml heparin). The nuclei
and debris were removed by centrifugation at 12,000×g
for 5 min, and the supernatants were loaded onto 10–
50% sucrose gradients and performed as described previ-
ously [84]. Subpolysomal and polysomal fractions were
pooled, and alongside the input RNA, the purified RNA
was subjected to 2.5M LiCl precipitation at 4C over-
night, followed by 20 min centrifugation at 12,000 rpm.
The RNA was washed twice with 75% ethanol and resus-
pended in H2O. Four micrograms of RNA of total, sub-
polysomal, and polysomal RNA was subjected to library
preparation using the TruSeq Stranded mRNA library
preparation kit followed by NextSeq500 High Output 75
cycle sequencing. For puromycin treatment, cells were
harvested as above, omitting cycloheximide, and treated
with 100 μg/ml puromycin for 3 min prior to scraping
into ice cold PBS. Control cells were treated with an
equivalent amount of DMSO. Gradients and extraction
were performed as above. Individual fractions for the
puromycin-treated samples (Additional file 1: Figure
S11B) and the control and CNOT1 siRNA experiments
(Additional file 1: Figure S9B, S10) were collected, and
RNA was prepared as above with LiCl precipitation.
Equal volumes of each fraction (1 μl) were subjected to
RT-qPCR, as described above. Relative amounts in each
fraction were calculated by comparing to signal from all
fractions. The experiments were performed in triplicate.
Protein production and purification
cDNAs corresponding to eIF4A1, eIF4A2, and eIF4H
were cloned into pET-SUMO vector and heterologously
produced in E. coli BL21 (DE3) CodonPlus-RP as N-
terminal SUMO-fusion proteins. Biomass was produced
applying standard protocols for IPTG-induction. Cells
were harvested, resuspended, and lysed in buffer A (20
mM Tris/HCl, pH 7.5, 1M NaCl, 30 mM imidazole, and
10% (v/v) glycerol) supplemented with 1 mM PMSF and
complete EDTA-free protease inhibitor cocktail (Roche).
After centrifugation at 75,000g supernatant was filtered
(0.45 μm) and applied to HisTrap (GE Healthcare) affin-
ity chromatography. Bound protein was eluted with a
linear imidazole gradient. Pooled fractions were diluted
in buffer B (20 mM Tris/HCl, pH 7.5, 10% (v/v) glycerol,
0.1 mM EDTA) and incubated with SUMO-protease for
1 h at 8 °C for cleavage of the SUMO-tag. The protein
solutions were further diluted with buffer B and applied
to a ResourceQ (GE Healthcare) anion exchange chro-
matography. Bound protein was eluted with a linear KCl
gradient. Pooled fractions were further purified by size
exclusion chromatography using a Superdex 200 column
equilibrated in storage buffer (20 mM Hepes/KOH, pH
7.5., 100 mM KCl, 0.1 mM EDTA, 10% (v/v) glycerol, 1
mM TCEP). Pooled fractions were concentrated, snap-
frozen in liquid nitrogen, and stored at − 80 °C. Protein
concentrations were calculated from the absorbance at
280 nm (A280) using extinction coefficients 34,630M-1
cm-1 (eIF4A1) and 40,130M-1 cm-1 (eIF4A2) obtained
from ExPASy server. All protein preparation showed an
A280/A260 ratio of ≥ 1.9 indicating negligible amounts
of contaminations by nucleic acids and nucleotides.
Fluorescence anisotropy assay
For RNA-binding studies, 10 nM FAM-labeled RNAs
(Sigma) were incubated with proteins (0–40 μM) in
binding buffer (BB, 20 mM Hepes/KOH, pH 7.5, 100
KCl, 1 mM MgCl2, 1 mM AMP-PNP, 1 mM TCEP, 0.1%
DMSO) in the presence and absence of 50 μM silvestrol
in 20 μl reactions for 60 min at 25 °C. For experiments,
protein-RNA complexes were formed by incubation of
1 μM FAM-labeled RNA with 1 μM protein in BB in the
presence or absence of 50 μM silvestrol. Strand release
was induced by addition of 20-fold excess of unlabelled
(AG)10-RNA. For dilution-induced strand release,
protein-RNA complexes were pre-formed as described
above, or with 10 nM FAM-labeled RNA and 1 or 3 μM
protein in the presence or absence of 50 μM silvestrol,
respectively. Strand release was induced by 1:1 dilution
of the reactions with BB. Fluorescence anisotropy was
measured using a Victor X5 (Perkin Elmer). Dissociation
constants and half-lives were obtained from fitting the
experimental data to the Hill- and single-exponential
decay equation.
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Binding selectivity assay
To investigate selectivity in RNA-binding studies, 0–7 μM
proteins were incubated simultaneously with 25 nM
Dy780-(AG)10 ssRNA (IBA life science) and 1–50-fold
molar excess of competitor ssRNAs (CAA)6CA or A20 in
binding buffer in the presence or absence of 50 μM silves-
trol in 20 μl reactions for 60min at 25 °C. Samples were
adjusted to 5% (v/v) glycerol, and protein-RNA complexes
were resolved by electrophoresis on TB-acrylamide gels.
After separation, gels were incubated for 5min in 10% (v/
v) acetic acid and bands corresponding to the labeled
RNA visualized using an Odyssey scanner (Licor) and sig-
nals were quantified using ImageStudio (Licor). Dissoci-
ation constants were derived from fitting the fraction
bound versus protein concentration to the Hill equation
using Prism GraphPad.
Informatic methods
All scripts used in the analyses are available upon
request.
RNA-Seq analysis
FASTQ files were aligned to the human genome (hg19)
using TopHat2 [85]. Alignment files were then trans-
formed into raw count data using htseq-count [86]. Dif-
ferential expression was performed using EdgeR [87].
Sucrose gradient NGS analysis
Differential expression analysis was conducted for
CNOT1 knockdown compared to control for subpolyso-
mal and polysomal fractions. Only genes significantly
(FDR < 0.05) altered in both fractions were then used in
plots in Fig. 5b. For polysome association, FPKM values
from the control siRNA subpolysomal fraction were sub-
tracted from those of the polysomal fraction to obtain a
measure of mRNA distribution between these fractions
(Fig. 2b, Additional file 1: Figure S4B). These were used
for polysome association density plots.
RIP-Seq enrichment analysis
Performed similarly to previous RIP-Seq studies [50, 88].
Ribosome profiling data processing and analysis
For RPF samples, Cutadapt was used to remove adapter
sequences then PCR duplicates were removed using cd-
hit-dup. The unique molecular identifiers were then re-
moved with Cutadapt. First, the reads were aligned to
rRNA and tRNA sequences and then to the hg19 tran-
scriptome using bowtie. The number of mapped reads
28–30 nt in length for each replicate was 23, 33, and 41
million. The positions of the reads were counted using a
modified script from RiboCounts selecting for read
lengths 28–30 nt, and the reads that showed periodicity
were retained for downstream analysis.
For total RNA samples, Cutadapt was used to remove
adapter sequences then PCR duplicates were removed
using cd-hit-dup. The reads were aligned to the hg19
transcriptome using Hisat2 and read counts obtained
using HTseq-count. The most abundant transcript for
each gene was used in downstream analysis.
Custom R scripts were used for downstream analysis.
To avoid bias due to multiple mRNA isoforms, the most
abundant transcript in the total RNA samples was used
as the representative transcript for each gene. Only tran-
scripts with at least 25 RPF reads and CDS length
greater than 300 nt were included in the analysis.
In Fig. 2c and Additional file 1: Figure S11A, for the
ribosome occupancy plots, RPF read counts were nor-
malized for library size and an offset of 13 applied to the
28–30 nt RPF fragments. Transcripts per million (TPM)
was calculated for total RNA samples as a measure of
mRNA abundance. RPF read counts at each position of
the transcript were divided by the TPM of the transcript
to account for the mRNA abundance. Plotted is the
mean normalized RPF read counts at each codon pos-
ition 75 codons into the CDS from the AUG and STOP
codon.
In Fig. 2f, the ribosome occupancy for the first 50 nt
and last 50 nt of 5′UTRs (5′UTR length greater than
100 nt) of the mRNAs was calculated in the same way
described above for Fig. 2c but using RPFs from all
frames.
GO term enrichment analysis
Performed using the Gene Ontology enrichment tool
[89] using hierarchical sorting and retaining the most
relevant child terms with Fisher’s exact test, only terms
with FDR < 0.05 were considered significant.
Sequences used in mRNA feature analysis
Sequences used in the analysis were derived from RefSeq
annotations based on gene ID [90]; only unique se-
quences were considered.
GA-tetramer enrichment
5′UTR, CDS, and 3′UTR sequences were obtained from
the RefSeq database based on gene ID. The non-
overlapping occurrence of the polypurine motif was
counted for each of the regions using eight of the most
enriched purine-rich motifs identified using Bind-n-Seq
in Iwasaki et al. [37] (AAGA|AGAA|GAAA|GAGA|A-
GAG|GGAA|AAAA|GAAG). Motif frequency is calcu-
lated to account for sequence length. p values were
obtained using the dunnTest with Bonferroni’s correc-
tion, part of the FSA package in R studio. For positional
calculations, the occurrence of the eight motifs above
was calculated per base in the first and last 50 nt of the
5′UTR (Fig. 3d) and corrected for gene number in each
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group and enrichment was calculated compared to
values for all mRNAs detected in the RIP-Seq experi-
ment. Statistical significance was calculated as above.
For the motif analysis, MEME was used for selective en-
richment of motifs between eIF4A2- and eIF4A1-bound
mRNAs. The MEME settings used were as follows: -rna
–mod zoops –minw 6 –maxw 8 –objfun se.
3′UTR analysis
Pumilio binding sites in the 3′UTR were calculated
using the regular expression TGTA(A|C|G|T)ATA [91].
For control 3′UTRs, mRNAs bound by DDX6, eIF4A2,
or both proteins were excluded from the group of all de-
tected mRNAs. Enrichment of conserved miRNA family
targets was calculated using Fisher’s exact test on Tar-
getscan7 target predictions conserved miRNA families
for human mRNA, with PCT > 0.5 [92].
Statistical methods
For luciferase assays, all data represent three biological
repeats unless stated otherwise. Error bars represent
standard deviation. Significance is determined using a t
test (two-tailed, paired). Statistical significance in figures
is as follows: *p < 0.05, **p < 0.01, ***p < 0.001, and n.s.—
not significant.
Structure superimposition
The human eIF4A1 sequence was mapped onto the
yeast eIF4A structure (PDB: 2vso) using Pymol.
Antibodies used for Western blotting
The antibodies used are as follows: eIF4A1 (Abcam
ab31217 1:1000), eIF4A2 (Abcam ab31218 1:1000; Santa
Cruz sc-137148 1:1000), eIF4A pan (Cell Signaling
2013 1:1000), DDX6 (Abcam ab70455 1:1000, ab54611
1:1000), CNOT1 (ATLAS HPA 046577 1:500), GAPVD1
(Sigma SAB 1401626), TRIM32 (Abcam ab96612 1:500),
CLP1 (Sigma SAB 1407080), CNOT7 (Abcam, ab57095),
eIF4GI (Cell Signaling 1:500), EDC3 (Bethyl A303-986A-
T 1:1000), GAPDH (Protein technologies 60004-1-Ig 1:
5000), TNRC6A (Novus Biologicals, NBP1-28751, 1:
2000), Vinculin (Abcam, ab18058 1:1000), and Flag
(Sigma, F1804 1:1000).
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